Firefly Neuroscience, Inc.
AIFF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,349 | $39,902 | $113,332 | $1,168,732 |
| - Cash | $1,810 | $2,143 | $58 | $653 |
| + Debt | $694 | $0 | $0 | $1,788 |
| Enterprise Value | $16,233 | $37,759 | $113,274 | $1,169,867 |
| Revenue | $108 | $498 | $0 | $32 |
| % Growth | -78.3% | – | -100% | – |
| Gross Profit | $41 | $498 | $0 | $32 |
| % Margin | 38% | 100% | – | 100% |
| EBITDA | -$10,322 | -$2,584 | -$3,201 | -$3,817 |
| % Margin | -9,557.4% | -518.9% | – | -11,928.1% |
| Net Income | -$10,460 | -$2,603 | -$3,789 | -$4,381 |
| % Margin | -9,685.2% | -522.7% | – | -13,690.6% |
| EPS Diluted | -1.6 | -0.33 | -0.48 | -0.56 |
| % Growth | -384.8% | 31.2% | 14.3% | – |
| Operating Cash Flow | -$6,155 | -$2,172 | -$2,892 | -$3,820 |
| Capital Expenditures | -$415 | -$386 | $0 | $0 |
| Free Cash Flow | -$6,570 | -$2,558 | -$2,892 | -$3,820 |